Psst! Do you accept cookies?
We use cookies to enhance and personalise your experience.
Please accept our cookies. Checkout our Cookie Policy for more information.
For cancer patients, medicines administered in clinical trials can help save or extend lives. But despite thousands of trials in the United States each year, only 3% to 5% of eligible patients enroll in investigations of new treatments. Triomics, a generative AI startup, claims it can significantly reduce the time it takes doctors to match […]
© 2024 TechCrunch. All rights reserved. For personal use only.
It seems like this feed has limited content. Do you want to fetch full content?
FetchUnfortunately, we're not able to fetch full content in this moment,
Do you want to check full content in the source blog?
Author: TechCrunch
Date: May 9, 2024
Permalink: owlver.com/s/caZbR8bP
A story from Owlver Network.
What's your thoughts?
Please Register or Login to your account to be able to submit your comment.